Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sue Fletcher

Showing results (111-120 of 173) with videos related to

Pageof 18
Sort By:
International Journal of Molecular Sciences|March 28, 2024
A Precision Therapy Approach for Retinitis Pigmentosa 11 Using Splice-Switching Antisense Oligonucleotides to Restore the Open Reading Frame of PRPF31Janya Grainok, Ianthe L Pitout, Fred K Chen, et al.
Pathology|September 8, 2011
Gene therapy: therapeutic applications and relevance to pathologyGerald Both, Ian Alexander, Sue Fletcher, et al.
Molecular and Cellular Pediatrics|February 8, 2018
The potential of antisense oligonucleotide therapies for inherited childhood lung diseasesKelly M Martinovich, Nicole C Shaw, Anthony Kicic, et al.
Autism : the International Journal of Research and Practice|October 28, 2015
A trial of an iPad™ intervention targeting social communication skills in children with autismSue Fletcher-Watson, Alexandra Petrou, Juliet Scott-Barrett, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|July 31, 2020
Eye-tracking for longitudinal assessment of social cognition in children born pretermBethan Dean, Lorna Ginnell, Victoria Ledsham, et al.
Current Developmental Disorders Reports|February 20, 2025
Applied Principles for Inclusive Practice in Neurodevelopmental Research: A Selection and Report of Illustrative Case StudiesSue Fletcher-Watson, Holly Joseph, Laura Crane, et al.
Plos One|May 1, 2013
Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophyChalermchai Mitrpant, Paul Porensky, Haiyan Zhou, et al.
Plos One|June 4, 2014
Antisense oligonucleotide induction of progerin in human myogenic cellsYue-Bei Luo, Chalermchai Mitrpant, Abbie M Adams, et al.
Scientific Reports|April 23, 2020
Splice modulating antisense oligonucleotides restore some acid-alpha-glucosidase activity in cells derived from patients with late-onset Pompe diseaseMay Thandar Aung-Htut, Kristin A Ham, Michel Tchan, et al.
International Journal of Clinical and Experimental Pathology|September 17, 2013
Investigation of splicing changes and post-translational processing of LMNA in sporadic inclusion body myositisYue-Bei Luo, Chalermchai Mitrpant, Russell Johnsen, et al.
Pageof 18

Showing results (111-120 of 173) with videos related to

Sort By:
Pageof 18
International Journal of Molecular Sciences|March 28, 2024
A Precision Therapy Approach for Retinitis Pigmentosa 11 Using Splice-Switching Antisense Oligonucleotides to Restore the Open Reading Frame of PRPF31Janya Grainok, Ianthe L Pitout, Fred K Chen, et al.
Pathology|September 8, 2011
Gene therapy: therapeutic applications and relevance to pathologyGerald Both, Ian Alexander, Sue Fletcher, et al.
Molecular and Cellular Pediatrics|February 8, 2018
The potential of antisense oligonucleotide therapies for inherited childhood lung diseasesKelly M Martinovich, Nicole C Shaw, Anthony Kicic, et al.
Autism : the International Journal of Research and Practice|October 28, 2015
A trial of an iPad™ intervention targeting social communication skills in children with autismSue Fletcher-Watson, Alexandra Petrou, Juliet Scott-Barrett, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|July 31, 2020
Eye-tracking for longitudinal assessment of social cognition in children born pretermBethan Dean, Lorna Ginnell, Victoria Ledsham, et al.
Current Developmental Disorders Reports|February 20, 2025
Applied Principles for Inclusive Practice in Neurodevelopmental Research: A Selection and Report of Illustrative Case StudiesSue Fletcher-Watson, Holly Joseph, Laura Crane, et al.
Plos One|May 1, 2013
Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophyChalermchai Mitrpant, Paul Porensky, Haiyan Zhou, et al.
Plos One|June 4, 2014
Antisense oligonucleotide induction of progerin in human myogenic cellsYue-Bei Luo, Chalermchai Mitrpant, Abbie M Adams, et al.
Scientific Reports|April 23, 2020
Splice modulating antisense oligonucleotides restore some acid-alpha-glucosidase activity in cells derived from patients with late-onset Pompe diseaseMay Thandar Aung-Htut, Kristin A Ham, Michel Tchan, et al.
International Journal of Clinical and Experimental Pathology|September 17, 2013
Investigation of splicing changes and post-translational processing of LMNA in sporadic inclusion body myositisYue-Bei Luo, Chalermchai Mitrpant, Russell Johnsen, et al.
Pageof 18